Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Aldosterone is a steroid hormone produced by the zona glomerulosa of the adrenal cortex in the adrenal gland. It acts as the primary mineralocorticoid in humans, playing a central role in the regulation of blood pressure and electrolyte balance by promoting sodium reabsorption and potassium secretion in the distal tubules and collecting ducts of the kidney. In the context of clinical research at Vanderbilt University, exogenous aldosterone is administered via intravenous infusion to investigate its physiological effects on glucose homeostasis. Specifically, researchers are exploring how elevated aldosterone levels contribute to insulin resistance and impaired insulin secretion, which are hallmark features of metabolic syndrome. This experimental use aims to clarify the link between hyperaldosteronism and the development of type 2 diabetes and other metabolic disorders.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on aldosterone.